Otonomy Reports Phase 2b Topline Data for OTO-104 in Meniere's Disease Narrowly missed primary endpoint of reduction in vertigo frequency during Month 3 following treatment compared to a one month baseline period, p = 0.067 Achieved statistical significance on...